Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics
Align before AMP Learn more about Quest Pathology
Call

Quest Diagnostics is bringing a new perspective to this year's Association for Molecular Pathology (AMP) Conference Annual Meeting and Expo. Stop by booth 2402 or sign up for time with our team using the link below. While visiting our booth, discover how our pathology solutions provide clarity and confidence across the care continuum.

Let's meet at AMP

  • Engage directly with our medical and commercial team members at our booth

  • Learn about our comprehensive molecular portfolio and how it can integrate with your workflows

  • Address TC/PC pathology lifecycle challenges with flexible global models, technical/professional component support, and modular histopathology solutions

Connect with our team at AMP

New research premiering at AMP

Optimizing FFPE tissue stewardship: Covaris truXTRAC automated workflow delivers excellent performance for tumor-informed Haystack MRD® assay

Presenters:

  • Eugenio Daviso, PhD - VP Solutions, Covaris
  • Sarabjot Pabla, PhD - Director of Bioinformatics, Quest Diagnostics

Wednesday, November 11

3:00 PM PST

YAKIMA 2, Level 1

Add to your schedule

Breadth and depth across multiple specialties

At Quest, we go beyond the test as your single-source solution, delivering reliable results, efficient processes, and world-class expertise across pathology specialties by leveraging over 350 board-certified pathologists and a comprehensive menu of services.

Learn about Haystack MRD® application in bladder cancer

Haystack MRD® is an advanced tumor-informed minimal residual disease (MRD) test that detects circulating tumor DNA (ctDNA) in blood using proprietary technology that double-checks each variant to eliminate sequencing noise. This helps clinicians trust the results to more fully understand their patient’s disease status for greater confidence when making key clinical decisions.
Learn more
Logo for Haystack MRD

OPERATIONALIZE YOUR PATHOLOGY VISION

Technical component (TC) and professional component (PC)

We know hospitals and health systems continue to face challenges associated with completing the technical component (TC) and professional component (PC) of the pathology life cycle, including the following:

  • Ongoing reimbursement pressures
  • Workload pressures
  • Increasing technology and supply costs

Quest can help by supporting your health system, hospital, or practice with our flexible TC/PC pathology solutions.

 

 

Learn more
Cultured cells growing in a petri dish under a microscope, symbolizing advancements in biomedical research. Generative AI

CUSTOMIZED FOR OPERATIONAL FLEXIBLITY AND CONTROL

Modular histopathology

With a complete portfolio of flexible models, from global services (technical and professional components) to medical directorships, Quest offers a collaborative approach that supports your existing workflows and clinical relationships—and delivers benefits beyond the test:

  • Operational efficiency
  • Consistent quality of collaboration
  • Scalable capacity to help support volume surges 

 

 

Learn more
Female doctor doing medical research medical samples, test tubes, at the lab.

Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.